JP7661248B2 - スルホニル尿素誘導体及びその使用 - Google Patents

スルホニル尿素誘導体及びその使用 Download PDF

Info

Publication number
JP7661248B2
JP7661248B2 JP2021573384A JP2021573384A JP7661248B2 JP 7661248 B2 JP7661248 B2 JP 7661248B2 JP 2021573384 A JP2021573384 A JP 2021573384A JP 2021573384 A JP2021573384 A JP 2021573384A JP 7661248 B2 JP7661248 B2 JP 7661248B2
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
compound
haloalkyl
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021573384A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022536160A5 (https=
JP2022536160A (ja
JPWO2020249664A5 (https=
Inventor
マーク ジー. ボック
デイビッド ハリソン
ジェーン イー. スカンロン
Original Assignee
ノッドセラ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ノッドセラ リミテッド filed Critical ノッドセラ リミテッド
Publication of JP2022536160A publication Critical patent/JP2022536160A/ja
Publication of JP2022536160A5 publication Critical patent/JP2022536160A5/ja
Publication of JPWO2020249664A5 publication Critical patent/JPWO2020249664A5/ja
Application granted granted Critical
Publication of JP7661248B2 publication Critical patent/JP7661248B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
JP2021573384A 2019-06-12 2020-06-11 スルホニル尿素誘導体及びその使用 Active JP7661248B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962860664P 2019-06-12 2019-06-12
US62/860,664 2019-06-12
PCT/EP2020/066185 WO2020249664A1 (en) 2019-06-12 2020-06-11 Sulfonylurea derivatives and uses thereof

Publications (4)

Publication Number Publication Date
JP2022536160A JP2022536160A (ja) 2022-08-12
JP2022536160A5 JP2022536160A5 (https=) 2023-06-20
JPWO2020249664A5 JPWO2020249664A5 (https=) 2023-06-20
JP7661248B2 true JP7661248B2 (ja) 2025-04-14

Family

ID=71108562

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021573384A Active JP7661248B2 (ja) 2019-06-12 2020-06-11 スルホニル尿素誘導体及びその使用

Country Status (6)

Country Link
US (1) US20230083495A1 (https=)
EP (1) EP3983407B1 (https=)
JP (1) JP7661248B2 (https=)
CN (1) CN114222739B (https=)
ES (1) ES3056339T3 (https=)
WO (1) WO2020249664A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
PL3983387T3 (pl) 2019-06-12 2024-08-19 NodThera Limited Pochodne sulfonylomocznika i ich zastosowania
CN117279903A (zh) * 2021-02-10 2023-12-22 杭州英创医药科技有限公司 作为nlrp3抑制剂的化合物
EP4729514A1 (en) 2023-06-14 2026-04-22 Haisco Pharmaceutical Group Co., Ltd. Bicyclic derivative parp inhibitor and use thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018015445A1 (en) 2016-07-20 2018-01-25 NodThera Limited Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
JP2019512009A (ja) 2016-02-16 2019-05-09 ザ・ユニバーシティ・オブ・クイーンズランド スルホニルウレアおよび関連化合物ならびにこれらの利用
WO2020035464A1 (en) 2018-08-15 2020-02-20 Inflazome Limited Novel sulfonamideurea compounds
WO2020035466A1 (en) 2018-08-15 2020-02-20 Inflazome Limited Novel sulfoneurea compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
JPS60214785A (ja) * 1984-03-27 1985-10-28 Nissan Chem Ind Ltd ピラゾ−ルスルホニルウレア誘導体、および植物生長調節剤または除草剤
DE4039734A1 (de) * 1990-12-13 1992-06-17 Basf Ag Substituierte 2-aminothiophene enthaltende herbizide mittel
DE4217719A1 (de) * 1992-05-29 1993-12-02 Bayer Ag Zweifach heterocyclisch substituierte Sulfonylamino(thio)carbonylverbindungen
JP3355237B2 (ja) * 1993-10-15 2002-12-09 呉羽化学工業株式会社 N−(置換アミノ)ピロール誘導体、その製造方法及び除草剤
JPH0827147A (ja) * 1994-07-20 1996-01-30 Kureha Chem Ind Co Ltd N−(置換アミノ)イミド誘導体、その製造方法及び除草剤
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
GB201721185D0 (en) * 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019512009A (ja) 2016-02-16 2019-05-09 ザ・ユニバーシティ・オブ・クイーンズランド スルホニルウレアおよび関連化合物ならびにこれらの利用
WO2018015445A1 (en) 2016-07-20 2018-01-25 NodThera Limited Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
WO2020035464A1 (en) 2018-08-15 2020-02-20 Inflazome Limited Novel sulfonamideurea compounds
WO2020035466A1 (en) 2018-08-15 2020-02-20 Inflazome Limited Novel sulfoneurea compounds

Also Published As

Publication number Publication date
ES3056339T3 (en) 2026-02-19
US20230083495A1 (en) 2023-03-16
JP2022536160A (ja) 2022-08-12
EP3983407A1 (en) 2022-04-20
CN114222739A (zh) 2022-03-22
WO2020249664A1 (en) 2020-12-17
EP3983407C0 (en) 2025-11-12
CN114222739B (zh) 2025-02-11
EP3983407B1 (en) 2025-11-12

Similar Documents

Publication Publication Date Title
KR102735310B1 (ko) Nlrp3 인플라마좀 조절제로서의 설포닐 우레아 유도체
CN111356680B (zh) Nlrp3炎性体的选择性抑制剂
JP7661248B2 (ja) スルホニル尿素誘導体及びその使用
JP7682813B2 (ja) スルホニル尿素誘導体及びその使用
JP2022535955A (ja) スルホンアミド誘導体及びその使用
US20250206745A1 (en) Pyrrolopyridazine derivatives and related uses
HK40039990B (en) Sulphonyl urea derivatives as nlrp3 inflammasome modulators
HK40039990A (en) Sulphonyl urea derivatives as nlrp3 inflammasome modulators
EA047011B1 (ru) Производные сульфонилмочевины в качестве модуляторов nlrp3 инфламмасомы
HK40031620A (en) Selective inhibitors of nlrp3 inflammasome
HK40031620B (en) Selective inhibitors of nlrp3 inflammasome

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230519

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230609

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230609

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240516

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240523

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240814

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240821

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250130

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250310

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250402

R150 Certificate of patent or registration of utility model

Ref document number: 7661248

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150